Vindico Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $13M
Latest Deal Amount

Vindico General Information

Description

Developer of nanometer-scale particulate technologies intended for a wide range of medical diagnostic and therapeutic applications. The company is dedicated to the discovery, development, and commercialization of highly innovative products, thereby enabling healthcare providers to advance and improve their standard of patient care

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • A169, ASTeCC
  • University of Kentucky
  • Lexington, KY 40506
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vindico Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 10-Oct-2016 $13M 00.000 0000 Completed Startup
2. Angel (individual) 25-Feb-2015 00.000 00.000 Completed Startup
1. Grant 01-Jan-2011 $900K Completed Startup
To view Vindico’s complete valuation and funding history, request access »

Vindico Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Vindico’s complete investors history, request access »